Hiroshi Okamura¹, Mika Nakamae¹, Makoto Moriguchi¹, Yusuke Okayama¹, Nao Tanizawa¹, Yumi Tagaito¹, Tetsuya Hayashi¹, Kazuki Sakatoku¹, Kentaro Ido¹, Naonori Harada¹, Satoru Nanno¹, Yasuhiro Nakashima¹, Hideo Koh¹, Takahiko Nakane¹, Asao Hirose¹, Kohei Yabusaki², Masayuki Hino¹, Hirohisa Nakamae¹ (1.Hematology, Osaka City University, Osaka, Japan, 2.Medical Statistics, Osaka City University, Osaka, Japan)

Yoshinobu Aisa, Yuriko Fujita, Masahiro Akimoto, Ayana Uchimura, Shinji Ogura, Tomohiko Tanigawa, Chisako Ito, Aki Sakurai, Tomonori Nakazato (Hematol, Yokohama Municipal Citizen's Hospital, Yokohama, Japan)

Miyo Goto^1,2, Masafumi Ito³, Tomoe Ichiki², Yuka Kawaguchi², Motohito Okabe², Yoonha Lee², Marie Ohbiki², Masahide Osaki², Hiroaki Araie², Tatsunori Goto², Takanobu Morishita², Yukiyasu Ozawa², Koichi Miyamura² (1.Dept. Hematol./Oncol., Konan Kosei Hospital, Aichi, Japan, 2.Dept. Hematol., Japanese Red Cross Nagoya First Hospital, Aichi, Japan, 3.Dept. Pathol., Japanese Red Cross Nagoya First Hospital, Aichi, Japan)

Takuma Ohashi¹, Jun Aoki¹, Taiki Ando², Yasufumi Ishiyama², Yoshimi Ishii¹, Kazuho Miyashita¹, Yuki Nakajima¹, Takayoshi Tachibana², Maki Hagihara³, Kenji Matsumoto³, Masatsugu Tanaka², Heiwa Kanamori², Shin Fujisawa¹, Hideaki Nakajima³ (1.Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan, 2.Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan, 3.Department of Hematology and Immunology, Yokohama City University, Yokohama, Japan)

Sachiko Seo¹, Junya Kanda², Yoshihiro Inamoto³, Keisuke Kato⁴, Kazuteru Ohashi⁵, Takahiro Fukuda³, Koji Iwato⁶, Yukiyasu Ozawa⁷, Tetsuya Eto⁸, Naoyuki Uchida⁹, Masashi Sawa¹⁰, Tatsuo Ichinohe¹¹, Yoshiko Atsuta¹², Fumihiko Kimura¹³ (1.Hematology & Oncology, Dokkyo Medical University, Tochigi, Japan, 2.Graduate School of Medicine, Kyoto University, Kyoto, Japan, 3.National Cancer Center Hospital, Tokyo, Japan, 4.Ibaraki Children's Hospital, Ibaraki, Japan, 5.Komagome Hospital, Tokyo, Japan, 6.Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan, 7.Japanese Red Cross Nagoya First Hospital, Aichi, Japan, 8.Hamanomachi Hospital, Fukuoka, Japan, 9.Toranomon Hospital, Tokyo, Japan, 10.Anjo Kosei Hospital, Aichi, Japan, 11.Hiroshima University, Hiroshima, Japan, 12.Japanese Data Center for Hematopoietic Cell Transplantation, Aichi, Japan, 13.National Defense Medical College Hospital, Saitama, Japan)

Yoshitaka Inoue¹, Toshiro Kawakita², Kisato Nosaka¹, Michihiro Hidaka², Masao Matsuoka¹ (1.Department of Hematology, Kumamoto University Hospital, Kumamoto, Japan, 2.Department of Hematology, Kumamoto Medical Center, Kumamoto, Japan)

Naomi Kawashima¹, Yuichi Ishikawa¹, Yoshiko Atsuta², Masashi Sawa³, Yukiyasu Ozawa⁴, Masaki Hayashi⁵, Akio Kohno⁶, Akihiro Tomita⁷, Tomoya Maeda⁸, Emiko Sakaida⁹, Kensuke Usuki¹⁰, Maki Hagihara¹¹, Heiwa Kanamori¹², Hiroshi Matsuoka¹³, Miki Kobayashi¹⁴, Norio Asou⁸, Shigeki Ohtake¹⁵, Itaru Matsumura¹⁶, Yasushi Miyazaki¹⁷, Tomoki Naoe¹⁸, Hitoshi Kiyoi¹ (1.Department of Hematology and Oncology, Nagoya University, 2.Japanese Data Center for Hematopoietic Cell Transplantation, 3.Department of Hematology and Oncology, Anjo Kosei Hospital, 4.Department of Hematology, Japanese Red Cross Nagoya First Hospital, 5.Department of Hematology, Nakagami Hospital, 6.Department of Hematology and Oncology, JA Aichi Konan Kosei Hospital, 7.Department of Hematology, Fujita Health University, 8.Department of Hemato-Oncology, International Medical Center, Saitama Medical University, 9.Department of Hematology, Chiba University Hospital, 10.Department of Hematology, NTT Medical Center Tokyo, 11.Department of Hematology and Clinical Immunology, Yokohama City University Hospital, 12.Department of Hematology, Kanagawa Cancer Center, 13.The Division of Medical Oncology and Hematology, Kobe University Hospital, 14.Department of Hematology, Japanese Red Cross Nagoya Daini Hospital, 15.Kanazawa University, 16.Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University, 17.Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, 18.Department of Hematology, National Hospital Organization Nagoya Medical Center)